BIAL sells allergic immunotherapy business to Roxall – The Pharma Letter (registration)
The Pharma Letter (registration) |
BIAL sells allergic immunotherapy business to Roxall
The Pharma Letter (registration) Portuguese pharmaceutical firm BIAL has agreed to sell its allergic immunotherapy business to German company Roxall. Known as BIAL Aristegui, the business is dedicated to the development, production and commercialization of anti-allergic vaccines and … |
